Banner

Clinical Trials

Text + image

<h3 style="white-space:pre-line"><span style="color:#3598db">A Feasibility Study Exploring the Effect of the</span><br /><span style="color:#3598db">MobiusHD Device in Patients with Heart Failure</span></h3>
<p>Study Design</p>
<ul>
<li>Prospective, open-label clinical trial</li>
<li>Subjects to be seen at the following intervals: 1 week, 1, 3, 6, 12, 18, and 24 months</li>
</ul>
<p>Key Eligibility Criteria</p>
<ul>
<li>Suitable carotid artery anatomy</li>
<li>Stable Guideline Directed Medical Therapy (GDMT)</li>
<li>LVEF ≤ 40%</li>
<li>NYHA Class III</li>
<li>6MWD distance of 150 to 400m</li>
<li>NT-proBNP ≥ 400 pg/mL</li>
</ul>

<h3 style="white-space:pre-line"><span style="color:#3598db">Confirmatory Evidence (n=21)</span></h3>
<ul>
<li>All patients were successfully implanted with the MobiusHD device in pre-procedurally determined locations</li>
<li>Initial evidence through 12 months FU shows favorable effects on cardiac function and clinical profile</li>
<li>Improved quality of life (KCCQ OSS)</li>
<li>Increased exercise tolerance 6MWD</li>
<li>Improved NYHA class </li>
</ul>

Clinical Trials

A Feasibility Study Exploring the Effect of theMobiusHD Device in Patients with Heart Failure

Confirmatory Evidence (n=21)

A Feasibility Study Exploring the Effect of the
MobiusHD Device in Patients with Heart Failure